O T C
Dyadic International (NASDAQ: DYAI): A Unique Approach to World Vaccination (DYAI, AZN, MRNA, NVAX, PFE, JNJ, BNTX)

The vaccine story is set to take yet another twist and turn in the months ahead as the Biden administration faces the literally world-shaping task of playing a material leadership role in helping to vaccinate the entire world against Covid-19. This comes after better-than-expected results in the pathway to bringing something rapidly closing in on

For long term investors looking for exposure to the booming green industry, MedX Holdings, Inc. (OTC US: MEDH) and Marijuana Company of America, Inc. (OTC US: MCOA) could light up your portfolio this year

According to recent research reports, the green industry is expected to more than double in value by 2025, and many investors are getting ready to ride the next green wave. As more U.S states and countries all over the world decriminalize or legalize the green substance, cannabis stocks may be the best investments you can

Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings

  Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin® line of pain relief products to their marketplace   Plantation, Florida, June 8, 2021 — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™, and Equine Pain-Away™ in the over-the-counter (OTC)

heliosDX and RushNet Inc. Sign Binding Letter of Intent to Acquire Laboratory and Target Additional Laboratory Acquisitions

  Alpharetta, GA, June 7, 2021 – RushNet, Inc (OTC PINK: RSHN) (“RushNet”) with merger/acquisition target heliosDX, is pleased to announce a Binding Letter of Intent by heliosdDX to acquire a privately held laboratory with $10,000,000 annual revenues processing more than 5,000 tests monthly with a capacity of 12,000 monthly UDS tests. The acquisition further

Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

  Plantation, Florida, June 4, 2021 – Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away, Luxury Feet and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today their plans for increasing sales

PsyKey Inc. Appoints Mental Health Professional Ms. Tessa Lawlor, B.A, M.A. to its Strategic Advisory Board

  CARSON CITY, NV, June 2, 2021 – CECORS, INC. (OTC US: CEOS) (“CeCors” or the “Company”), through its wholly-owned subsidiary PsyKey Inc., is pleased to announce the appointment of mental health professional and advocate Ms. Tessa Lawlor, B.A, M.A. to its Strategic Advisory Board. Ms. Lawlor obtained her Master of Arts in Counselling Psychology

Professional Snowboarder Jake Vedder Joins Nutra Pharma in Endorsing Nyloxin for Chronic Pain Relief

  Nutra Pharma announces that professional snowboarder and wakeboarder, Jake Vedder, is endorsing Nyloxin for Chronic Pain Relief as part of their social media and influencer campaign   Plantation, Florida, June 2, 2021 — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain

The Vaccine Investment Hypothesis, and What’s Next (AZN, JNJ, DYAI, BNTX)

The party is apparently “On” as far as the developed world’s sense of “reopening” is concerned. But the global truth is far removed from this celebration, as less than 20% of the world’s population have had access to a vaccine. The major vaccine producers struggle with the unit economics and production dynamics to solve this

PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market

  Sandusky, OH, May 27, 2021 – McapMediaWire — PAO Group, Inc. (OTC Pink: PAOG) today highlighted Alkame Holdings, Inc’s (OTC Pink: ALKM) recent news reporting the near completion status of its new production facility: ALKM – Alkame Confirms $15 Million Annual Revenue Bottling Production Potential PAOG recenlty released a preview of the company’s plan

SUPURVA HEALTHCARE GROUP, INC. ADVOCATES MEDICAL REAL ESTATE AS AN EFFECTIVE HEDGE AGAINST INFLATION

  Liverpool, New York, May 27, 2021 – McapMediaWire – Supurva Healthcare Group, Inc. (OTC Pink: SPRV) (“SPRV”) (the “Company”) announced today that John Murphy President and CEO recently stated that macroeconomic trends that include the Government’s COVID -19 stimulus packages, reduced unemployment, and increases in GDP, strongly indicate inflation is on the horizon in

Recent Posts

Recent Posts

Contact Us

All Rights Reserved © 2019